Skip to main content
WAT
NYSE Industrial Applications And Services

Waters Corp Beats Q1 Estimates, Raises Full-Year Revenue & EPS Guidance on Strong Organic Growth and Acquired Business Performance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$311
Mkt Cap
$29.634B
52W Low
$275.05
52W High
$414.15
52W Position info
13% above low
Off High info
25% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

WAT is trading near its 52-week low of $275.05 (13% above the low).

Summary

Waters Corporation announced strong first-quarter results, beating adjusted EPS and revenue estimates, and subsequently raised its full-year 2026 financial guidance.


Key Events · Earnings and Guidance · WAT

  • Q1 Financial Outperformance

    Waters Corporation reported first-quarter 2026 adjusted EPS of $2.70, surpassing analyst estimates, and total reported revenue of $1.267 billion, which exceeded the high end of guidance by $56 million.

  • Strong Organic Revenue Growth

    Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of constant currency growth guidance by 200 basis points, driven by high-single-digit instrument growth and mid-teens chemistry growth.

  • Acquired Businesses Exceed Expectations

    The Biosciences and Diagnostic Solutions businesses, acquired on February 9, 2026, generated $520 million in reported revenue since the acquisition close, outperforming guidance by $40 million in their first reporting period under Waters' ownership.

  • Raised Full-Year 2026 Guidance

    The company raised its full-year 2026 organic constant currency revenue growth guidance to 6.5% to 8.0% and increased its adjusted EPS guidance to a range of $14.40 to $14.60, reflecting double-digit adjusted EPS growth.


Analysis · WAT · Industrial Applications And Services

Waters Corporation reported robust first-quarter results, with adjusted EPS of $2.70 significantly surpassing analyst estimates and total revenue exceeding the high end of its guidance range. This strong performance was driven by exceptional organic revenue growth and better-than-expected contributions from the recently acquired Biosciences and Diagnostic Solutions businesses, marking a successful initial integration period for the significant acquisition. The company's decision to raise its full-year 2026 revenue and adjusted EPS guidance signals increased confidence in sustained momentum and operational execution, providing a positive outlook for investors.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WAT was trading at $311.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $29.6B. The 52-week trading range was $275.05 to $414.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WAT - Latest Insights

WAT
Nov 10, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $475.52
Real-time Price: $449.78 info
Change: -$25.74 (-5%) info
Market Cap: $44.207B info
WAT
Nov 03, 2026, 8:11 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $456.00
Real-time Price: $449.78 info
Change: -$6.22 (-1%) info
Market Cap: $44.207B info
WAT
Nov 03, 2026, 6:12 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $457.00
Real-time Price: $449.78 info
Change: -$7.22 (-2%) info
Market Cap: $44.207B info
WAT
Aug 11, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $414.59
Real-time Price: $449.78 info
Change: +$35.19 (+8%) info
Market Cap: $44.207B info
WAT
Aug 04, 2026, 7:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $373.00
Real-time Price: $449.78 info
Change: +$76.78 (+21%) info
Market Cap: $44.207B info